Xencor | XNCR - Current Liabilities


Xencor reported $86.48M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 39.39B 376M Sep/2025
Alnylam Pharmaceuticals USD 1.56B 254.63M Sep/2025
Amgen USD 21.79B 1.32B Sep/2025
Arrowhead Research USD 195.49M 957K Sep/2025
AstraZeneca USD 34.05B 518M Sep/2025
Biogen USD 3.29B 106.3M Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Cytokinetics USD 142.14M 11.08M Sep/2025
GlaxoSmithKline GBP 21.33B 956M Sep/2025
J&J USD 50.87B 3.31B Sep/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Regeneron Pharmaceuticals USD 4.43B 758.1M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Xencor USD 86.48M 9.6M Sep/2025